SIENQ — Sientra Share Price
0.000.00%
Last trade - 00:00- $1.19m
- $44.98m
- $90.55m
- 25
- 63
- 10
- 24
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.01 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -61.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 68.13 | 83.7 | 55 | 80.68 | 90.55 | 87.4 | 93.7 | 19.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
Directors
- Caroline Van Hove CHM (41)
- Ronald Menezes PRE (58)
- Andrew Schmidt CFO (59)
- Oliver Bennett CCO (44)
- Valerie Miller VPR (55)
- Denise Dajles VRD
- Keith Sullivan DRC (61)
- Nori Ebersole IND (57)
- Irina Erenburg IND (51)
- Mary Fisher IND (58)
- Kevin O'Boyle IND (63)
- Philippe Schaison IND (57)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- August 29th, 2003
- Public Since
- October 29th, 2014
- No. of Shareholders
- 216
- No. of Employees
- 304
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 11,957,712
- Address
- 3333 Michaelson Dr, Suite 650, IRVINE, 92612
- Web
- https://sientra.com/
- Phone
- +1 8055623500
- Auditors
- KPMG LLP
Upcoming Events for SIENQ
Q1 2024 Sientra Inc Earnings Release
Sientra Inc Annual Shareholders Meeting
Q2 2024 Sientra Inc Earnings Release
Similar to SIENQ
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
What is the Sientra share price?
As of Today at 19:19 UTC, shares in Sientra are trading at $0.10. This share price information is delayed by 15 minutes.
How has the Sientra share price performed this year?
Shares in Sientra last closed at $0.10 and the price had moved by -92.6% over the past 365 days. In terms of relative price strength the Sientra share price has underperformed the S&P500 Index by -93.61% over the past year.
What are the analyst and broker recommendations for Sientra?
The overall consensus recommendation for Sientra is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sientra dividend yield?
Sientra does not currently pay a dividend.
Does Sientra pay a dividend?
Sientra does not currently pay a dividend.
When does Sientra next pay dividends?
Sientra does not currently pay a dividend.
How do I buy Sientra shares?
To buy shares in Sientra you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sientra?
As of the previous close price of $0.10, shares in Sientra had a market capitalisation of $1.19m.
Where are Sientra shares listed?
Here are the trading details for Sientra:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SIENQ
What kind of share is Sientra?
Based on an overall assessment of its quality, value and momentum Sientra is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sientra share price forecast for 2024?
The analyst consensus target price for shares in Sientra is $2.00. That is 1902% above the last closing price of $0.10.
Analysts covering Sientra currently have a consensus Earnings Per Share (EPS) forecast of -$3.94 for the next financial year.
What is the trend in the Sientra share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sientra. Over the past six months, its share price has underperformed the S&P500 Index by -94.29%.
As of the last closing price of $0.10, shares in Sientra were trading -92.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sientra PE Ratio?
The Sientra PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sientra?
Sientra's management team is headed by:
- Caroline Van Hove - CHM
- Ronald Menezes - PRE
- Andrew Schmidt - CFO
- Oliver Bennett - CCO
- Valerie Miller - VPR
- Denise Dajles - VRD
- Keith Sullivan - DRC
- Nori Ebersole - IND
- Irina Erenburg - IND
- Mary Fisher - IND
- Kevin O'Boyle - IND
- Philippe Schaison - IND